Cite

HARVARD Citation

    Cohen, E. et al. (2019). A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors. Journal for immunotherapy of cancer. 7 (1), p. . [Online]. 
  
Back to record